Raymond James, Sym

Palantir or AMD: Raymond James Chooses the Better AI Stock to Buy After Earnings
January finished with an earthquake in the tech world, when the Chinese startup DeepSeek released its new AI assistant – and revealed that it
Symbotic falls as Raymond James downgrades stock on disappointing earnings
Symbotic (NASDAQ:SYM) shares fell more than 17% in Thursday trade after Raymond James downgraded its rating from Outperform to Market Perform following a disappointing first quarter results. The Massachusetts-based warehouse automation company reported both top-line and bottom-line misses on Wednesday,
Raymond James downgrades Symbotic on execution concerns
Raymond James downgraded Symbotic Inc (NASDAQ:SYM) to "Market Perform" from "Outperform" on disappointing first-quarter results, weak second-quarter guidance, and concerns over the company's ability to scale system deployments efficiently.
Symbotic downgraded to Market Perform from Outperform at Raymond James
Raymond James downgraded Symbotic (SYM) to Market Perform from Outperform without a price target The company’s Q1 results and Q2 guidance
Ares Capital cut to Market Perform at Raymond James on valuation
Raymond James on Thursday downgraded Ares Capital (ARCC) shares to Market Perform from Outperform in what analyst Robert Dodd called a "valuation driven rationale, not a credit/portfolio issue."
Raymond James Downgrades Symbotic (SYM)
Fintel reports that on February 6, 2025, Raymond James downgraded their outlook for Symbotic (NasdaqGM:SYM) from Outperform to Market Perform. Analyst Price Forecast Suggests 15.29% Upside As of January 29,
Big Tech's underperformance is just a blip, says Raymond James' Larry Adam
Larry Adam, Raymond James chief investment officer, joins 'The Exchange' to discuss key takeaways from Big Tech earnings, ...
Raymond James Financial Inc. stock outperforms competitors on strong trading day
This was the stock's second consecutive day of gains.
InvestmentNews17h
LPL, Raymond James boost advisor ranks anew
LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...
Raymond James Has Negative Estimate for WFG FY2025 Earnings
Raymond James lowered their FY2025 earnings per share (EPS) estimates for West Fraser Timber in a research report issued on Monday, February 3rd. Raymond James analyst D. Swetlishoff now anticipates ...
Raymond James: Strong Balance Sheet And Cash Economics Are In The Price
Raymond James is seeing a beneficial shift to advisory as well as recovering M&A activity, which may continue. Read why I ...
Raymond James Becomes Latest Financial Firm to Dial Back on Reporting Advisor Head Count
Following similar moves by other large firms, Raymond James says quarterly advisor counts aren’t the most meaningful measure ...
Raymond James Has Optimistic View of TSE:MDP FY2025 Earnings
Equities research analysts at Raymond James boosted their FY2025 earnings per share (EPS) estimates for Medexus Pharmaceuticals in a report released on Monday, February 3rd. Raymond James analyst M.
Regenxbio resumed with an Outperform at Raymond James
Raymond James resumed coverage of Regenxbio (RGNX) with an Outperform rating and $27 price target The firm expects the launch of Elevidys and ...
Raymond James Upgrades Booz Allen Hamilton Holding (BAH) to ‘Outperform’ with $150 Target
As the global AI race heated up last month with the launch of DeepSeek R1 and Alibaba’s Qwen 2.5 AI models, US AI firms are ...
Financial Planning9d
Dynasty brings over $6.4B RIA from Raymond James
Jeffrey Dobyns, the president of SageSpring Wealth Partners, says he and his colleagues were looking for greater freedom to ...
Corpay price target lowered at Raymond James, says buy shares on weakness
Raymond James lowered the firm’s price target on Corpay (CPAY) to $417 from $434 and keeps an Outperform rating on the shares. Corpay reported ...